NCT03907475 2026-05-13Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ TrialNational Cancer Institute (NCI)Phase 2 Recruiting115 enrolled
NCT00761644 2019-04-11Doxil, Bevacizumab and Temsirolimus TrialM.D. Anderson Cancer CenterPhase 1 Completed200 enrolled